Plumeria Therapeutics
Princeton
About Plumeria Therapeutics
Plumeria Therapeutics mission is to create precise therapies for the treatment of neuro-inflammatory diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Estimated revenue: Less than $1M
- Total funding: $225.0K
- Last round: Grant (Oct 2024)
- Website: plumeriatherapeutics.com
- Phone: [email protected]
Industries & Categories
Clinical Trials, Health Diagnostics, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/plumeria-therapeutics-124888 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.